Pharmaceuticals

United States Inactivated Vaccines Market Report 2021

  • QYR684245
  • 103 Pages
  • August 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Inactivated Vaccines

Revenue, means the sales value of Inactivated Vaccines

This report studies sales (consumption) of Inactivated Vaccines in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

Astellas Pharma Inc

CSL Limited

Emergent BioSolutions, Inc

GlaxoSmithKline

Johnson & Johnson

MedImmune, LLC

Merck & Co

Pfizer

Sanofi Pasteur

Serum Institute

India Pvt. Ltd. (India)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Pneumococcal

Influenza

HPV

Hepatitis

Rotavirus

DTP

Polio

MMR

Split by applications, this report focuses on sales, market share and growth rate of Inactivated Vaccines in each application, can be divided into

Pediatric

Adult

Application 3

Table of Contents

United States Inactivated Vaccines Market Report 2021

1 Inactivated Vaccines Overview

1.1 Product Overview and Scope of Inactivated Vaccines

1.2 Classification of Inactivated Vaccines

1.2.1 Pneumococcal

1.2.2 Influenza

1.2.3 HPV

1.2.4 Hepatitis

1.2.5 Rotavirus

1.2.6 DTP

1.2.7 Polio

1.2.8 MMR

1.3 Applications of Inactivated Vaccines

1.3.1 Pediatric

1.3.2 Adult

1.3.3 Application 3

1.4 USA Market Size (Value and Volume) of Inactivated Vaccines (2011-2021)

1.4.1 USA Inactivated Vaccines Sales, Revenue and Price (2011-2021)

1.4.2 USA Inactivated Vaccines Sales and Growth Rate (2011-2021)

1.4.3 USA Inactivated Vaccines Revenue and Growth Rate (2011-2021)

2 USA Inactivated Vaccines Competition by Manufacturers

2.1 USA Inactivated Vaccines Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 USA Inactivated Vaccines Revenue and Share by Manufactures (2015 and 2016)

3 USA Inactivated Vaccines (Volume and Value) by Type

3.1 USA Inactivated Vaccines Sales and Market Share by Type (2011-2021)

3.2 USA Inactivated Vaccines Revenue and Market Share by Type (2011-2021)

4 USA Inactivated Vaccines (Volume) by Application

5 USA Inactivated Vaccines Manufacturers Analysis

5.1 Astellas Pharma Inc

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Inactivated Vaccines Product Type and Technology

5.1.2.1 Pneumococcal

5.1.2.2 Influenza

5.1.3 Inactivated Vaccines Sales, Revenue, Price of Astellas Pharma Inc (2015 and 2016)

5.2 CSL Limited

5.2.1 Company Basic Information,Manufacturing Base and Competitors

5.2.2 Pharmaceuticals Product Type and Technology

5.2.2.1 Pneumococcal

5.2.2.2 Influenza

5.2.3 Pharmaceuticals Sales, Revenue, Price of CSL Limited (2015 and 2016)

5.3 Emergent BioSolutions, Inc

5.3.1 Company Basic Information,Manufacturing Base and Competitors

5.3.2 Emergent BioSolutions, Inc Product Type and Technology

5.3.2.1 Pneumococcal

5.3.2.2 Influenza

5.3.3 Emergent BioSolutions, Inc Sales, Revenue, Price of Emergent BioSolutions, Inc (2015 and 2016)

5.4 GlaxoSmithKline

5.4.1 Company Basic Information,Manufacturing Base and Competitors

5.4.2 Sanofi Pasteur Product Type and Technology

5.4.2.1 Pneumococcal

5.4.2.2 Influenza

5.4.3 GlaxoSmithKline Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)

5.5 Johnson & Johnson

5.5.1 Company Basic Information,Manufacturing Base and Competitors

5.5.2 Johnson & Johnson Product Type and Technology

5.5.2.1 Pneumococcal

5.5.2.2 Influenza

5.5.3 Johnson & Johnson Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)

5.6 MedImmune, LLC

5.6.1 Company Basic Information,Manufacturing Base and Competitors

5.6.2 MedImmune, LLC Product Type and Technology

5.6.2.1 Pneumococcal

5.6.2.2 Influenza

5.6.3 MedImmune, LLC Sales, Revenue, Price of MedImmune, LLC (2015 and 2016)

5.7 Merck & Co

5.7.1 Company Basic Information,Manufacturing Base and Competitors

5.7.2 Merck & Co Product Type and Technology

5.7.2.1 Pneumococcal

5.7.2.2 Influenza

5.7.3 Merck & Co Sales, Revenue, Price of Merck & Co (2015 and 2016)

5.8 Pfizer

5.8.1 Company Basic Information,Manufacturing Base and Competitors

5.8.2 Pfizer Product Type and Technology

5.8.2.1 Pneumococcal

5.8.2.2 Influenza

5.8.3 Pfizer Sales, Revenue, Price of Pfizer (2015 and 2016)

5.9 Sanofi Pasteur

5.9.1 Company Basic Information,Manufacturing Base and Competitors

5.9.2 Sanofi Pasteur Product Type and Technology

5.9.2.1 Pneumococcal

5.9.2.2 Influenza

5.9.3 Sanofi Pasteur Sales, Revenue, Price of Sanofi Pasteur (2015 and 2016)

5.10 Serum Institute

5.10.1 Company Basic Information,Manufacturing Base and Competitors

5.10.2 Serum Institute Product Type and Technology

5.10.2.1 Pneumococcal

5.10.2.2 Influenza

5.10.3 Serum Institute Sales, Revenue, Price of Serum Institute (2015 and 2016)

5.11 India Pvt. Ltd. (India)

6 Inactivated Vaccines Technology and Development Trend

6.1 Inactivated Vaccines Technology Analysis

6.2 Inactivated Vaccines Technology Development Trend

7 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Inactivated Vaccines

Table Classification of Inactivated Vaccines

Figure USA Sales Market Share of Inactivated Vaccines by Type in 2015

Figure Pneumococcal Picture

Figure Influenza Picture

Figure HPV Picture

Figure Hepatitis Picture

Figure Rotavirus Picture

Figure DTP Picture

Figure Polio Picture

Figure MMR Picture

Table Applications of Inactivated Vaccines

Figure USA Sales Market Share of Inactivated Vaccines by Application in 2015

Figure Pediatric Examples

Figure Adult Examples

Table USA Inactivated Vaccines Sales, Revenue and Price (2011-2021)

Figure USA Inactivated Vaccines Sales and Growth Rate (2011-2021)

Figure USA Inactivated Vaccines Revenue and Growth Rate (2011-2021)

Table USA Inactivated Vaccines Sales of Key Manufacturers (2015 and 2016)

Table USA Inactivated Vaccines Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Inactivated Vaccines Sales Share by Manufacturers

Figure 2016 Inactivated Vaccines Sales Share by Manufacturers

Table USA Inactivated Vaccines Revenue by Manufacturers (2015 and 2016)

Table USA Inactivated Vaccines Revenue Share by Manufacturers (2015 and 2016)

Table 2015 USA Inactivated Vaccines Revenue Share by Manufacturers

Table 2016 USA Inactivated Vaccines Revenue Share by Manufacturers

Table USA Inactivated Vaccines Sales and Market Share by Type (2011-2021)

Table USA Inactivated Vaccines Sales Share by Type (2011-2021)

Figure Sales Market Share of Inactivated Vaccines by Type (2011-2021)

Figure USA Inactivated Vaccines Sales Growth Rate by Type (2011-2021)

Table USA Inactivated Vaccines Revenue and Market Share by Type (2011-2021)

Table USA Inactivated Vaccines Revenue Share by Type (2011-2021)

Figure Revenue Market Share of Inactivated Vaccines by Type (2011-2021)

Figure USA Inactivated Vaccines Revenue Growth Rate by Type (2011-2021)

Table USA Inactivated Vaccines Sales and Market Share by Application (2011-2021)

Table USA Inactivated Vaccines Sales Share by Application (2011-2021)

Figure Sales Market Share of Inactivated Vaccines by Application (2011-2021)

Figure USA Inactivated Vaccines Sales Growth Rate by Application (2011-2021)

Table Astellas Pharma Inc Basic Information List

Table Inactivated Vaccines Sales, Revenue, Price of Astellas Pharma Inc (2015 and 2016)

Table CSL Limited Basic Information List

Table Inactivated Vaccines Sales, Revenue, Price of CSL Limited (2015 and 2016)

Table Emergent BioSolutions, Inc Basic Information List

Table Inactivated Vaccines Sales, Revenue, Price of Emergent BioSolutions, Inc (2015 and 2016)

Table GlaxoSmithKline Basic Information List

Table Inactivated Vaccines Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)

Table Johnson & Johnson Basic Information List

Table Inactivated Vaccines Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)

Table MedImmune, LLC Basic Information List

Table Inactivated Vaccines Sales, Revenue, Price of MedImmune, LLC (2015 and 2016)

Table Merck & Co Basic Information List

Table Inactivated Vaccines Sales, Revenue, Price of Merck & Co (2015 and 2016)

Table Pfizer Basic Information List

Table Inactivated Vaccines Sales, Revenue, Price of Pfizer (2015 and 2016)

Table Sanofi Pasteur Basic Information List

Table Inactivated Vaccines Sales, Revenue, Price of Sanofi Pasteur (2015 and 2016)

Table Serum Institute Basic Information List

Table Inactivated Vaccines Sales, Revenue, Price of Serum Institute (2015 and 2016)

Table India Pvt. Ltd. (India) Basic Information List

Table Inactivated Vaccines Sales, Revenue, Price of India Pvt. Ltd. (India) (2015 and 2016)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370